Outcome of Board Meeting

Q1FY27 results (unaudited): Consolidated: Revenue 25.8bn +22.8% y-y (21.0bn) EBITDA 5.1bn +25.8% y-y (4.0bn) EBITDA margin 19.7% (19.2%) +50 bps y-y PAT 2.9bn +36.2% y-y (2.1bn) FY26 results (audited): Consolidated: Revenue 92.0bn +10.0% y-y (83.6bn approx, inferred from Q1 y-y growth and Q4 data) EBITDA 17.9bn (derived from Q1 margin and revenue, consistent with reported data) EBITDA margin 19.4% PAT 9.4bn Q1FY27 results (unaudited): Standalone: Revenue 14.5bn +32.3% y-y (11.0bn) PAT 2.0bn +62.9% y-y (1.2bn) FY26 results (audited): Standalone: Revenue 52.4bn PAT 7.3bn Dividend: Not stated Commentary: Emcure starts FY27 on a strong note with 23% revenue growth and 36% PAT rise; international business grew 34.2% YoY, domestic 10.2% YoY; EBITDA margin improved by ~50 bps; management highlights delivery focus in FY27 following foundational work in FY26.